Fluorouracil - Malignant and pre-malignant skin lesions
You are here : Home > Formulary Search > Fluorouracil - Malignant and pre-malignant skin lesions
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Fluorouracil
Indication :
Malignant and pre-malignant skin lesions
Group Name :
Keywords :
Superficial basal cell carcinoma, melanoma, skin cancer
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
20 May 09 -
Surrey Medicines Commissioners Group
The committee agreed that it should be a RED drug on the traffic light system if initiated following an out-patient appointment by a secondary care specialist / GPSI as the cost of the drug is included within PbR tariff. However, it was agreed that GPs may make an individual clinical decision to prescribe for recurrent skin lesions after initial diagnosis
Other Indications
Below are listed other indications that Fluorouracil is used to treat.